Wordt geladen...
Real‐world efficacy and potential mechanism of resistance of icotinib in Asian advanced non‐small cell lung cancer with EGFR uncommon mutations: A multi‐center study
The response to icotinib in advanced non‐small cell lung cancers (NSCLC) with EGFR uncommon mutation (EGFRum) is unclear. Here we reported the efficacy and potential resistance mechanism of icotinib in Chinese EGFRum NSCLC patients. Between July 2013 and November 2016, 3117 NSCLC patients were scree...
Bewaard in:
| Gepubliceerd in: | Cancer Med |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6943154/ https://ncbi.nlm.nih.gov/pubmed/31692291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2652 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|